 Announced Multi-Target Drug Discovery Collaboration with Zentalis Pharmaceuticals in Oncology --- Granted Two Patents for Compounds that Stabilize G-Case for Gauchers Disease and other Synucleinopathies including Parkinsons Disease, Lewy Body Dementia and Alzheimers Disease --- 43.2 Million in Cash as of June 30, 2021, Provides Runway into Second half of 2023 and a Strong Cash Position to Advance the Companys Programs 